CRP	C REACTIVE PROTEIN
HMG-CoA	HYDROXY 3 METHYLGLUTARYL COENZYME A
hs-CRP	HIGH SENSITIVE C REACTIVE PROTEIN
HER2	HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
CVD	CARDIOVASCULAR DISEASE	CV DISEASES
OPG	OSTEOPROTEGERIN
RANK	RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KB	RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPAB
RANKL	RANK LIGAND
HCY	HOMOCYSTEINE
HHCY	HCY LEVELS
OP	OSTEOPOROSIS
CKD	CHRONIC KIDNEY DISEASE
VKA	VITAMIN K ANTAGONISTS
OA	ORAL ANTICOAGULANTS
OC	OSTEOCALCIN	ORGANIC CARBON
BMP-2	BONE MORPHOGENETIC PROTEIN 2
QOL	QUALITY OF LIFE
PT	PSEUDOTUMOUR
IBD	INFLAMMATORY BOWEL DISEASE
TG	THROMBIN GENERATION
CAT	CALIBRATED AUTOMATED THROMBOGRAPHY
PUCAI	PEDIATRIC ULCERATIVE COLITIS DISEASE ACTIVITY INDEX
ETP	ENDOGENOUS THROMBIN POTENTIAL
PL	PHOSPHOLIPIDS
PRP	PLATELET RICH PLASMA
VWD	VON WILLEBRAND DISEASE
CoNS	COAGULASE NEGATIVE STAPHYLOCOCCI
MRSA	METHICILLIN RESISTANT STAPHYLOCOCCI	METHICILLIN RESISTANT S. AUREUS
MSSA	METHICILLIN SUSCEPTIBLE STAPHYLOCOCCCI
MIH	MOLAR INCISOR HYPOMINERALIZATION
PPV	POSITIVE PREDICTIVE VALUE
NPV	NEGATIVE PREDICTIVE VALUE
DV	DIRECT VISUAL
IDV	INDIRECT VISUAL
TMD	TEMPOROMANDIBULAR DISORDERS
HED	HYPOHIDROTIC ECTODERMAL DYSPLASIA
JRP	JUVENILE RECURRENT PAROTITIS
LADD	LACRIMO AURICULODENTO DIGITAL	LACRIMO AURICULO DENTO DIGITAL
FGFR2	FIBROBLAST GROWTH FACTOR RECEPTORS 2
LAIs	LONG ACTING INJECTIONS	LONG ACTING ANTIPSYCHOTICS
FGA	FIRST GENERATION ANTIPSYCHOTIC
FGA-LAIs	FIRST GENERATION ANTIPSYCHOTIC LONG ACTING INJECTIONS
RCTs	RANDOMISED CONTROLLED TRIALS
SGAs	SECOND GENERATION ANTIPSYCHOTICS
LAI	LONG ACTING INJECTION
CTO	COMMUNITY TREATMENT ORDER
SGA	SECOND GENERATION ANTIPSYCHOTIC
NBS	NEWBORN SCREENING
CF	CYSTIC FIBROSIS
CRMS	CFTR RELATED METABOLIC SYNDROME
EHCN	EUROPEAN HEALTHY CITIES NETWORK
CHPs	CITY HEALTH PROFILES
HIA	HEALTH IMPACT ASSESSMENT
EU	EUROPEAN UNION
CHDP	CITY HEALTH DEVELOPMENT PLANNING
HUP	HEALTHY URBAN PLANNING
WHO-EHCN	WHO EUROPEAN HEALTHY CITIES NETWORK
HPVs	HUMAN PAPILLOMAVIRUSES
CIN	CERVICAL INTRAEPITHELIAL NEOPLASM
ICC	INVASIVE CANCER OF THE CERVIX
IMID	IMMUNE MEDIATED INFLAMMATORY DISEASES
TNF	TUMOR NECROSIS FACTOR	TUMOUR NECROSIS FACTOR
mTOR	MAMMALIAN TARGET OF RAPAMYCIN
HPV	HUMAN PAPILLOMAVIRUS
LBJ	LYNDON B. JOHNSON
IPPE	INTRODUCTORY PHARMACY PRACTICE EXPERIENCE
APPE	ADVANCED PHARMACY PRACTICE EXPERIENCE
ARI	ACUTE RESPIRATORY INFECTION
PCI	PERCUTANEOUS CORONARY INTERVENTIONS	PERCUTANEOUS CORONARY INTERVENTION
OQ	OPPRESSION QUESTIONNAIRE
BMI	BODY MASS INDEX
PSI	PATIENT SAFETY INDICATORS
MBDS	MINIMUM BASIC DATA SET
AEs	ADVERSE EVENTS
IDEA	IDENTIFICATION OF ADVERSE
AE	ADVERSE EVENTS	AGRYPNIA EXCITATA
CPA	CARDIOPULMONARY ARREST
ICUs	INTENSIVE CARE UNITS
SCS	SAFETY CLIMATE SURVEY
ICU	INTENSIVE CARE UNIT
NCCN	NATIONAL COMPREHENSIVE CANCER NETWORK
MIT	MELODIC INTONATION THERAPY
BoNTA	BOTULINUM TOXIN TYPE A
LCLs	LATERAL CANTHAL LINES
LCAs	LATERAL CANTHAL AREAS
HA	HYALURONIC ACID
FWS	FACIAL WRINKLE SCALE
BoNT-A	BOTULINUM TOXIN TYPE A
AA	ALOPECIA AREATA
BTXA	BOTULINUM TOXIN TYPE A
BT	BOTULINUM TOXIN
CSTF	COMPLETE SECONDARY THERAPY FAILURE
SIADH	SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE
AVP	ARGININE VASOPRESSIN
GABA	Γ AMINOBUTYRIC ACID
mBC	METASTATIC BREAST CANCER
RCT	RANDOMISED CONTROLLED TRIAL
PFS	PROGRESSION FREE SURVIVAL
FACT-B	FUNCTIONAL ASSESSMENT OF CANCER THERAPY FOR BREAST
ICERs	INCREMENTAL COST EFFECTIVENESS RATIOS
EUP	EUROPEAN UNION POPULATION
CS	CLINICALLY SIGNIFICANT
CSS	CLINICALLY SIGNIFICANT SEVERE
ITP	IDIOPATHIC THROMBOCYTOPENIC PURPURA
ICER	INCREMENTAL COST EFFECTIVENESS RATIO
QALY	QUALITY ADJUSTED LIFE YEAR
IHC	IMMUNOHISTOCHEMISTRY
FISH	FLUORESCENCE IN SITU HYBRIDISATION
5-FU	5 FLUOROURACIL
EOX	EPIRUBICIN, OXALIPLATIN,
ECF	EPIRUBICIN, CISPLATIN, 5 FU
HCF	HCX OR TRASTUZUMAB, CISPLATIN, 5 FU
QALYs	QUALITY ADJUSTED LIFE YEARS
PAC-QOL	PATIENT ASSESSMENT OF CONSTIPATION QUALITY OF LIFE
PAC-SYM	PATIENT ASSESSMENT OF CONSTIPATION SYMPTOMS
EQ-5D	EUROPEAN QUALITY OF LIFE 5 DIMENSIONS
RR	RELATIVE RISK
CLL	CHRONIC LYMPHOCYTIC LEUKAEMIA
OS	OVERALL SURVIVAL
DR	DOUBLE REFRACTORY
BSC	BEST SUPPORTIVE CARE
PLDH	PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE
MTC	MIXED TREATMENT COMPARISON
SBP	SYSTOLIC BLOOD PRESSURE
PsA	PSORIATIC ARTHRITIS
PsARC	PSORIATIC ARTHRITIS RESPONSE CRITERIA
HAQ	HEALTH ASSESSMENT QUESTIONNAIRE
TV	TOTAL VARIATION
FBP	FILTERED BACKPROJECTION
CT	COMPUTED TOMOGRAPHY
FFMCT	FLUENCE FIELD MODULATED CT
IMRT	INTENSITY MODULATED RADIATION THERAPY
SNR	SIGNAL TO NOISE RATIO
ROIs	REGIONS OF INTEREST
NPWE	NONPREWHITENING MATCHED FILTER WITH AN EYE
PC	PROPORTION CORRECT
2-AFC	TWO ALTERNATIVE FORCED CHOICE
VRT	VOLUME RENDERING TECHNIQUES
DBP	DIFFERENTIAL BACKPROJECTION
BPF	BACKPROJECTION FILTRATION
CaSR	CALCIUM SENSING RECEPTOR
PK	PROTEIN KINASE
PPAR	PEROXISOME PROLIFERATOR ACTIVATOR
rP	RELATED PEPTIDE
PHPT	PRIMARY HYPERPARATHYROIDISM
MEN	MULTIPLE ENDOCRINE NEOPLASIA	MULTIPLE ENDOCRINE NEOPLASIA
HPTJT	HYPERPARATHYROIDISM JAW TUMOR
FIHP	FAMILIAL ISOLATED HYPERPARATHYROIDISM
FHH	FAMILIAL HYPOCALCIURIC HYPERCALCEMIA
NSHPT	NEONATAL SEVERE HYPERPARATHYROIDISM
CASR	CALCIUM SENSING RECEPTOR
P-HPT	PRIMARY HYPERPARATHYROIDISM
BMD	BONE MINERAL DENSITY
aPHPT	ASYMPTOMATIC PHPT
EPIQ	EVIDENCE BASED PRACTICE FOR IMPROVING QUALITY
NICU	NEONATAL INTENSIVE CARE UNIT
PHO	PROVINCIAL HEALTH OFFICER
RICHER	RESPONSIVE, INTERSECTORAL INTERDISCIPLINARY, CHILD COMMUNITY, HEALTH, EDUCATION AND RESEARCH
IPC	INTER PROFESSIONAL CARE	INTERPROFESSIONAL COLLABORATION
PAC	PAEDIATRIC ASTHMA CLINIC
ASHCN	ADOLESCENTS WITH SPECIAL HEALTHCARE NEEDS
fFn	FETAL FIBRONECTIN
PBS	POSITIVE BEHAVIOUR SUPPORT
TCP	THROMBOCYTOPATHY
PTT	PARTIAL THROMBOPLASTIN TIME
MLPA	MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION
EMG	ELECTROMYOGRAPHY	ELECTROMYOGRAPHIC
VWJS	VON WILLEBRAND JÜRGENS SYNDROME
OCA	OCULOCUTANEOUS ALBINISM
HPS	HERMANSKY PUDLAK SYNDROME
BD	BLEEDING DISORDERS
IGE	IDIOPATHIC GENERALIZED EPILEPSY
IED	INTERICTAL EPILEPTIFORM DISCHARGES
AD	AROUSAL DISORDERS	ATOPIC DERMATITIS
NFLE	NOCTURNAL FRONTAL LOBE EPILEPSY
FFI	FATAL FAMILIAL INSOMNIA
DT	DELIRIUM TREMENS
MS	MORVAN SYNDROME
SEEG	STEREO EEG
iRBD	IDIOPATHIC REM SLEEP BEHAVIOR DISORDER
RBD	REM SLEEP BEHAVIOR DISORDER	REM SLEEP BEHAVIOUR DISORDER
REM	RAPID EYE MOVEMENT
NC-RBD	NOT CLINICAL RBD
SD	STATUS DISSOCIATUS
AOR	ADJUSTED ODDS RATIO
HLHS	HYPOPLASTIC LEFT HEART SYNDROME
ADHD	ATTENTION DEFICIT HYPER ACTIVITY DISORDER	ATTENTION DEFICIT HYPERACTIVITY DISORDER
DIVA	DIAGNOSTISCH INTERVIEW VOOR ADHD
ASRS	ADULT SELF REPORT SCALE
fMRI	FUNCTIONAL MAGNETIC RESONANCE IMAGING
ERP	EVENT RELATED POTENTIALS
ASD	AUTISM SPECTRUM DISORDERS	AUTISM SPECTRUM DISORDER
BRIEF	BEHAVIOR RATING INVENTORY FOR EXECUTIVE FUNCTION
OnabotA	ONABOTULINUMTOXIN A
RS	RHINOSINUSITIS
AOM	ACUTE OTITIS MEDIA
CRS	CHRONIC RHINOSINUSITIS
PROs	PATIENT REPORTED OUTCOMES
HRQL	HEALTH RELATED QUALITY OF LIFE
VARC	VALVE ACADEMIC RESEARCH CONSORTIUM
PVL	PARAVALVULAR LEAK
TAVI	TRANSCATHETER AORTIC VALVE IMPLANTATION
AR	AORTIC REGURGITATION
PV	PARAVALVULAR
MR	MITRAL REGURGITATION
TAVR	TRANSCATHETER AORTIC VALVE REPLACEMENT
DFM	DIRECT FLOW MEDICAL
THV	TRANSCATHETER HEART VALVE	TRANSCATHETER HEART VALVES
PA	PITYRIASIS ALBA
IGA	INVESTIGATOR GLOBAL ASSESSMENT
VAS	VISUAL ANALOGUE SCALE
ADCs	ANTIBODY DRUG CONJUGATES
DCE	DYNAMIC CONTRAST ENHANCED
DWI	DIFFUSION WEIGHTED IMAGING
STDs	SEXUALLY TRANSMITTED DISEASES
JDH	JOURNAL OF DENTAL HYGIENE
EBDM	EVIDENCE BASED DECISION MAKING
PEG-IFN	PEGYLATED INTERFERON
cTn	CARDIAC TROPONINS
hs	HIGH SENSITIVITY
AMI	ACUTE MYOCARDIAL INFARCTION
INR	INTERNATIONAL NORMALIZED RATIO
VKAs	VITAMIN K ANTAGONISTS
POC	POINT OF CARE
ACF	ABERRANT CRYPT FOCI
SIR	STANDARDIZED INCIDENCE RATIO
EAR	EXCESS ABSOLUTE RISK
RRT	RENAL REPLACEMENT THERAPY
pmp	PER MILLION POPULATION
ESRD	END STAGE RENAL DISEASE
HD	HEMODIALYSIS
PD	PERITONEAL DIALYSIS
HDF	HEMODIAFILTRATION
APD	AUTOMATED PERITONEAL DIALYSIS
CAPD	CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
FRISBEE	FRIENDLY SUMMARY OF THE BODY OF EVIDENCE USING EPISTEMONIKOS
CHF	CHRONIC HEART FAILURE
CPE	CARBAPENEMASE PRODUCING ENTEROBACTERIA
RAS	RECURRENT APHTHOUS STOMATITIS
DIC	DISSEMINATED INTRAVASCULAR COAGULATION
Abs	ANTIBODIES
CABG	CORONARY ARTERY BYPASS GRAFT
SVR	SURGICAL VENTRICULAR RECONSTRUCTION
AF	ATRIAL FIBRILLATION
HAART	HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
BURV	BURANA VIRUS
TAMV	TAMDY VIRUS
SDVFV	SYR DARYA VALLEY FEVER VIRUS
WMV	WAD MEDANI VIRUS
KEMV	KEMEROVO
EEEP	END EXPIRATORY ESOPHAGEAL PRESSURE
Ptp	PLATEAU PRESSURE
IAP	INTRA ABDOMINAL PRES
GFAP	GLIAL FIBRILLARY ACIDIC PROTEIN
mGluR	METABOTROPIC GLUTAMATE RECEPTOR
GC	GASTRIC CANCER
sPG	SERUM PEPSINOGENS
Hp	HELICOBACTER PYLORI
ALD	ALCOHOLIC LIVER DISEASE
TPOT	THE PRODUCTIVE OPERATING THEATRE
NAbs	NATURAL ANTIBODIES
LA	LANDOMYCIN A
ROS	REACTIVE OXYGEN SPECIES
NO	NITRIC OXIDE
BAL	BRONCHOALVEOLAR LAVAGE
OVA	OVALBUMIN
NMD	NEUROMUSCULAR DISEASES
LTS	LARYNGOTRACHEAL SEPARATION
TFM	TRACHEAL FLAP METHOD
PRES	POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
ALL	ACUTE LYMPHOCYTIC LEUKEMIA
ASL	ARTERIAL SPIN LABELING
EBV	EPSTEIN BARR VIRUS	EB VIRUS
EB	EPSTEIN BARR
PICU	PEDIATRIC INTENSIVE CARE UNIT
PCIS	PEDIATRIC CLINICAL ILLNESS SCORE	PEDIATRIC CRITICAL ILLNESS SCORE
PTX3	PENTRAXIN 3
ELISA	ENZYME LINKED IMMUNOSORBENT ASSAY
BNP	BRAIN TYPE NATRIURETIC PEPTIDE
PCT	PLASMA CALCITONIN
OI	OXYGENATION INDEX
HR	HEART RATE
MAP	MEAN ARTERIAL BLOOD PRESSURE
MODS	MULTIPLE ORGAN DYSFUNCTION SYNDROME
RT-PCR	REVERSE TRANSCRIPTION PCR
CA6	COXSACKIEVIRUS A6
CA16	COXSACKIEVIRUS A16
hsCRP	HIGH SENSITIVITY C REACTIVE PROTEIN
PRRT2	PROLINE RICH TRANSMEMBRANE PROTEIN 2
PKD	PAROXYSMAL KINESIGENIC DYSKINESIA
HIBCH	HYDROXY ISOBUTYRYL COA HYDROLASE
EC	ELEMENTAL CARBON
SOC	SECONDARY ORGANIC CARBON
TNH3	TOTAL NH3
VOCs	VOLATILE ORGANIC COMPOUNDS
L-PBS	LIPOSOMAL PBS
